Fifth Lane Capital »

Ocular Therapeutix shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $199k 17k 11.69

More positions owned by Fifth Lane Capital

Ishares Tr Core S&p500 Etf (IVV)
Renatus Tactical Acquis Shs Cl A (RTAC)
C1 Common Stock
Cantor Equity Partners Ii In Cl A Ord Shs (CEPT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Procap Acquisition Corp Shs Cl A
Cantor Equity Partners Iii I Shs Cl A (CAEP)
Futurecrest Acquisition Corp Unit 99/99/9999
M3brigade Acquisition V Corp Cl A (MBAV)
Wen Acquisition Corp Com Cl A
Columbus Circle Cap Corp. I Shs Cl A (BRR)
Btc Dev Corp Unit 09/11/2030
UnitedHealth (UNH)
Republic Digital Acquisition Usd Cl A Ord Shs (RDAG)
Live Oak Acquisition Corp V Cl A Shs (LOKV)

View all positions for Fifth Lane Capital

Top funds holding Ocular Therapeutix

FMR
VR Adviser
Summer Road
Deep Track Capital
BlackRock
venBio Select Advisor
Vanguard Group
TCG Crossover Management
Citadel Advisors
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Paradigm Biocapital Advisors
State Street Corporation
Alliancebernstein

View all funds holding Ocular Therapeutix